Filing Details
- Accession Number:
- 0001209191-21-063225
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-05 17:19:20
- Reporting Period:
- 2021-09-01
- Accepted Time:
- 2021-11-05 17:19:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1684087 | Caroline Young | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-10-01 | 15 | $2.69 | 13,688 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-04 | 15 | $2.87 | 13,703 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-05 | 15 | $2.82 | 13,718 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-06 | 15 | $2.76 | 13,733 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-07 | 15 | $2.76 | 13,748 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-08 | 15 | $2.84 | 13,763 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-11 | 15 | $2.73 | 13,778 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-12 | 15 | $2.71 | 13,793 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-13 | 15 | $2.71 | 13,808 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-14 | 15 | $2.81 | 13,823 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-15 | 15 | $2.76 | 13,838 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-18 | 15 | $2.75 | 13,853 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-19 | 15 | $2.76 | 13,868 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-20 | 15 | $2.63 | 13,883 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-21 | 15 | $2.65 | 13,898 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-22 | 15 | $2.66 | 13,913 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-25 | 15 | $2.64 | 13,928 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-26 | 15 | $2.64 | 13,943 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-27 | 15 | $2.61 | 13,958 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-28 | 15 | $2.61 | 13,975 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-10-29 | 15 | $2.72 | 13,988 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.